Cargando…

Identification of differentially methylated regions in rare diseases from a single-patient perspective

BACKGROUND: DNA methylation (5-mC) is being widely recognized as an alternative in the detection of sequence variants in the diagnosis of some rare neurodevelopmental and imprinting disorders. Identification of alterations in DNA methylation plays an important role in the diagnosis and understanding...

Descripción completa

Detalles Bibliográficos
Autores principales: Grolaux, Robin, Hardy, Alexis, Olsen, Catharina, Van Dooren, Sonia, Smits, Guillaume, Defrance, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758859/
https://www.ncbi.nlm.nih.gov/pubmed/36527161
http://dx.doi.org/10.1186/s13148-022-01403-7
_version_ 1784852129061535744
author Grolaux, Robin
Hardy, Alexis
Olsen, Catharina
Van Dooren, Sonia
Smits, Guillaume
Defrance, Matthieu
author_facet Grolaux, Robin
Hardy, Alexis
Olsen, Catharina
Van Dooren, Sonia
Smits, Guillaume
Defrance, Matthieu
author_sort Grolaux, Robin
collection PubMed
description BACKGROUND: DNA methylation (5-mC) is being widely recognized as an alternative in the detection of sequence variants in the diagnosis of some rare neurodevelopmental and imprinting disorders. Identification of alterations in DNA methylation plays an important role in the diagnosis and understanding of the etiology of those disorders. Canonical pipelines for the detection of differentially methylated regions (DMRs) usually rely on inter-group (e.g., case versus control) comparisons. However, these tools might perform suboptimally in the context of rare diseases and multilocus imprinting disturbances due to small cohort sizes and inter-patient heterogeneity. Therefore, there is a need to provide a simple but statistically robust pipeline for scientists and clinicians to perform differential methylation analyses at the single patient level as well as to evaluate how parameter fine-tuning may affect differentially methylated region detection. RESULT: We implemented an improved statistical method to detect differentially methylated regions in correlated datasets based on the Z-score and empirical Brown aggregation methods from a single-patient perspective. To accurately assess the predictive power of our method, we generated semi-simulated data using a public control population of 521 samples and investigated how the size of the control population, methylation difference, and region size affect DMR detection. In addition, we validated the detection of methylation events in patients suffering from rare multi-locus imprinting disturbance and evaluated how this method could complement existing tools in the context of clinical diagnosis. CONCLUSION: In this study, we present a robust statistical method to perform differential methylation analysis at the single patient level and describe its optimal parameters to increase DMRs identification performance. Finally, we show its diagnostic utility when applied to rare disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-022-01403-7.
format Online
Article
Text
id pubmed-9758859
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97588592022-12-18 Identification of differentially methylated regions in rare diseases from a single-patient perspective Grolaux, Robin Hardy, Alexis Olsen, Catharina Van Dooren, Sonia Smits, Guillaume Defrance, Matthieu Clin Epigenetics Research BACKGROUND: DNA methylation (5-mC) is being widely recognized as an alternative in the detection of sequence variants in the diagnosis of some rare neurodevelopmental and imprinting disorders. Identification of alterations in DNA methylation plays an important role in the diagnosis and understanding of the etiology of those disorders. Canonical pipelines for the detection of differentially methylated regions (DMRs) usually rely on inter-group (e.g., case versus control) comparisons. However, these tools might perform suboptimally in the context of rare diseases and multilocus imprinting disturbances due to small cohort sizes and inter-patient heterogeneity. Therefore, there is a need to provide a simple but statistically robust pipeline for scientists and clinicians to perform differential methylation analyses at the single patient level as well as to evaluate how parameter fine-tuning may affect differentially methylated region detection. RESULT: We implemented an improved statistical method to detect differentially methylated regions in correlated datasets based on the Z-score and empirical Brown aggregation methods from a single-patient perspective. To accurately assess the predictive power of our method, we generated semi-simulated data using a public control population of 521 samples and investigated how the size of the control population, methylation difference, and region size affect DMR detection. In addition, we validated the detection of methylation events in patients suffering from rare multi-locus imprinting disturbance and evaluated how this method could complement existing tools in the context of clinical diagnosis. CONCLUSION: In this study, we present a robust statistical method to perform differential methylation analysis at the single patient level and describe its optimal parameters to increase DMRs identification performance. Finally, we show its diagnostic utility when applied to rare disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-022-01403-7. BioMed Central 2022-12-16 /pmc/articles/PMC9758859/ /pubmed/36527161 http://dx.doi.org/10.1186/s13148-022-01403-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Grolaux, Robin
Hardy, Alexis
Olsen, Catharina
Van Dooren, Sonia
Smits, Guillaume
Defrance, Matthieu
Identification of differentially methylated regions in rare diseases from a single-patient perspective
title Identification of differentially methylated regions in rare diseases from a single-patient perspective
title_full Identification of differentially methylated regions in rare diseases from a single-patient perspective
title_fullStr Identification of differentially methylated regions in rare diseases from a single-patient perspective
title_full_unstemmed Identification of differentially methylated regions in rare diseases from a single-patient perspective
title_short Identification of differentially methylated regions in rare diseases from a single-patient perspective
title_sort identification of differentially methylated regions in rare diseases from a single-patient perspective
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758859/
https://www.ncbi.nlm.nih.gov/pubmed/36527161
http://dx.doi.org/10.1186/s13148-022-01403-7
work_keys_str_mv AT grolauxrobin identificationofdifferentiallymethylatedregionsinrarediseasesfromasinglepatientperspective
AT hardyalexis identificationofdifferentiallymethylatedregionsinrarediseasesfromasinglepatientperspective
AT olsencatharina identificationofdifferentiallymethylatedregionsinrarediseasesfromasinglepatientperspective
AT vandoorensonia identificationofdifferentiallymethylatedregionsinrarediseasesfromasinglepatientperspective
AT smitsguillaume identificationofdifferentiallymethylatedregionsinrarediseasesfromasinglepatientperspective
AT defrancematthieu identificationofdifferentiallymethylatedregionsinrarediseasesfromasinglepatientperspective